Metraipolis › archive › dc_91fa3d3aff1b
Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41020868
- DOI
- 10.3390/cimb47090746
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T00:46:18.842Z
- SHA-256 of the archived text
262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3- Stable URL of this page
https://metraipolis.com/documento/dc_91fa3d3aff1b
How to cite
Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868 — Europe PMC (en), https://europepmc.org/article/MED/41020868 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91fa3d3aff1b (Metraipolis archive dc_91fa3d3aff1b, sha256 262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3)
BibTeX
@misc{dc91fa3d3aff1b,
title = {Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41020868},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91fa3d3aff1b; sha256 262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020868. Agents can read the archived copy with the MCP tool read_document.